HEALEY ALS Platform Trial Regimen I enrolment completed - Topline results for NUZ-001 accelerated to Q2 CY2027

Data ReadoutNUZ-001Positive

AI Analysis

Summary

NUZ-001 completed enrollment in the HEALEY ALS Platform Trial with 250 participants in less than five months, representing the fastest enrollment to date. Topline efficacy and safety results have been accelerated to late Q2 2027.

Clinical Trial Data

Patients

250

Outcome Details

Topline efficacy and safety results anticipated

Importance:6/10

Sentiment:

0.60

ALSHEALEY Platform Trialenrollment completedaccelerated timeline

Related Companies

$TRAX

Read the original article

Published by PR Newswire Pharma on July 17, 2026 3:48 AM

Read Original